AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer ' s With Immunotherapy

With backing from some of biotech ' s biggest players, Alector, a startup taking on Alzheimer ' s disease announced Wednesday that it has raised $133 million in a Series E funding round.

Source: Forbes.com Healthcare News - July 25, 2018 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news